INAB

$0.00

(

+0.00%

)
Quote details

stock

In8bio Inc

NASDAQ | INAB

1.73

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 10, 2025)

$8.25M

Market Cap

-

P/E Ratio

-5.26

EPS

$12.54

52 Week High

$1.53

52 Week Low

HEALTHCARE

Sector

INAB Chart

Recent Chart
Price Action

INAB Technicals

Tags:

INAB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$2.7M
Total Revenue $0
Cost Of Revenue $2.7M
Costof Goods And Services Sold $2.7M
Operating Income -$30M
Selling General And Administrative $13M
Research And Development $17M
Operating Expenses $30M
Investment Income Net -
Net Interest Income $230K
Interest Income $230K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.7M
Income Before Tax -$30M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$30M
Comprehensive Income Net Of Tax -
Ebit -$30M
Ebitda -$27M
Net Income -$30M

Revenue & Profitability

Earnings Performance

INAB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $21M
Total Current Assets $13M
Cash And Cash Equivalents At Carrying Value $11M
Cash And Short Term Investments $11M
Inventory -
Current Net Receivables -
Total Non Current Assets $8.4M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.5M
Other Non Current Assets -
Total Liabilities $6.5M
Total Current Liabilities $3.1M
Current Accounts Payable $389K
Deferred Revenue -
Current Debt -
Short Term Debt $1.6M
Total Non Current Liabilities $3.4M
Capital Lease Obligations $5M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $5M
Other Current Liabilities $1M
Other Non Current Liabilities -
Total Shareholder Equity $14M
Treasury Stock -
Retained Earnings -$122M
Common Stock $7K
Common Stock Shares Outstanding $54M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$2.7M
Total Revenue $0
Cost Of Revenue $2.7M
Costof Goods And Services Sold $2.7M
Operating Income -$30M
Selling General And Administrative $13M
Research And Development $17M
Operating Expenses $30M
Investment Income Net -
Net Interest Income $230K
Interest Income $230K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.7M
Income Before Tax -$30M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$30M
Comprehensive Income Net Of Tax -
Ebit -$30M
Ebitda -$27M
Net Income -$30M

INAB Profile

In8bio Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

In8bio, Inc. is a New York-based clinical-stage biotechnology firm pioneering the development of innovative cancer therapies through genetically modified gamma-delta T cells. Focused on both autologous and allogeneic cell therapies, the company is strategically targeting solid tumors, thereby establishing itself as a key player in the immuno-oncology space. With a robust pipeline of proprietary treatments, In8bio is committed to meeting critical unmet needs in cancer care, aiming to deliver transformative solutions that could significantly alter the future of oncology therapeutics.

LPTX
+368.57%
$2.05
MNTS
+29.12%
$0.98
PAVS
-14.12%
$0.03
VHAI
-25.00%
$0.00
IRBT
+33.55%
$4.71
NVDA
-1.17%
$182.78
AXDX
-61.36%
$0.03
WOK
-95.22%
$0.26
IBIO
+25.55%
$2.78
ATPC
-93.45%
$0.08
ADAP
-15.14%
$0.05
ONDS
-6.17%
$8.66
SOND
-23.45%
$0.12
INTC
-0.38%
$40.34
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
BYND
+1.46%
$1.27
PLTR
+2.73%
$186.81
BNKK
-34.66%
$0.14
ENVB
+53.88%
$9.11
ASST
-4.56%
$0.97
UBER
-6.28%
$83.47
WBD
+3.57%
$29.27
ABEV
-2.02%
$2.42
MTSR
-0.35%
$70.50
SOFI
+1.06%
$27.11
NFLX
-2.55%
$94.24
DNN
-2.72%
$2.66
TSLA
-0.04%
$444.99
RGTI
-5.27%
$26.73
AFMD
-34.94%
$0.18
PLUG
0.00%
$2.21
RKLB
+6.21%
$56.75
KITT
+6.60%
$1.13
TE
+11.79%
$6.73
CGTL
+52.29%
$1.00
RIG
-3.59%
$4.29
CFLT
+0.18%
$29.95
GRYP
-10.38%
$1.38
POM
-88.29%
$0.63
HPE
+1.05%
$25.03
MODV
-25.22%
$0.43
BMNR
0.00%
$39.21
CHR
-2.67%
$0.04
AMZN
+1.08%
$230.40
ADVB
-5.59%
$0.34
GPK
-8.66%
$14.23
BBD
+0.30%
$3.33
QBTS
-2.48%
$27.62
EXK
+4.48%
$8.86
SIDU
+29.28%
$1.02
F
+0.22%
$13.11
DVLT
-6.36%
$1.47
TWOH
+16.66%
$0.00
GOOGL
-0.30%
$316.12
JBLU
+0.20%
$4.96
AAL
-1.36%
$14.82
BLNK
-7.43%
$0.93
CHWY
-1.23%
$34.41
IQ
-1.93%
$2.03
CRWV
-4.34%
$86.72
MSFT
-2.92%
$477.63
BBGI
+186.66%
$11.61
IREN
-4.80%
$44.58
BMNU
+0.79%
$10.79
GRAB
-0.87%
$5.10
CIFR
-3.60%
$18.85
HBAN
+1.20%
$17.19
SHOT
-74.37%
$0.39
BAC
+0.61%
$53.87
BTBT
-2.10%
$2.32
PFE
+0.50%
$25.45
KVUE
+1.26%
$17.23
ZAPP
-46.30%
$0.15
ACHR
-1.21%
$8.52
MARA
-2.89%
$11.89
PLTD
-2.98%
$6.33
IXHL
-5.53%
$0.39
MIGI
+56.24%
$7.18
PFSA
-6.95%
$0.18
SOLT
+9.15%
$8.35
HLN
-0.95%
$9.31
CVS
+2.23%
$78.24
SMR
-4.54%
$20.35
YGMZ
-17.83%
$0.05
COMP
+4.03%
$10.84
RDW
+6.89%
$7.29
BTE
-0.64%
$3.07
T
-0.22%
$24.45
QUBT
-4.80%
$12.57
WULF
-0.96%
$15.43
PLAB
+40.13%
$36.00
TNFA
-4.92%
$6.56
VZ
-0.57%
$39.90
IVP
-19.74%
$0.06
SPR
+0.22%
$39.50
NIO
+0.10%
$5.03
AMD
-1.07%
$219.23
LPTX
+368.57%
$2.05
MNTS
+29.12%
$0.98
PAVS
-14.12%
$0.03
VHAI
-25.00%
$0.00
IRBT
+33.55%
$4.71
NVDA
-1.17%
$182.78
AXDX
-61.36%
$0.03
WOK
-95.22%
$0.26
IBIO
+25.55%
$2.78
ATPC
-93.45%
$0.08
ADAP
-15.14%
$0.05
ONDS
-6.17%
$8.66
SOND
-23.45%
$0.12
INTC
-0.38%
$40.34
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
BYND
+1.46%
$1.27
PLTR
+2.73%
$186.81
BNKK
-34.66%
$0.14
ENVB
+53.88%
$9.11
ASST
-4.56%
$0.97
UBER
-6.28%
$83.47
WBD
+3.57%
$29.27
ABEV
-2.02%
$2.42
MTSR
-0.35%
$70.50
SOFI
+1.06%
$27.11
NFLX
-2.55%
$94.24
DNN
-2.72%
$2.66
TSLA
-0.04%
$444.99
RGTI
-5.27%
$26.73
AFMD
-34.94%
$0.18
PLUG
0.00%
$2.21
RKLB
+6.21%
$56.75
KITT
+6.60%
$1.13
TE
+11.79%
$6.73
CGTL
+52.29%
$1.00
RIG
-3.59%
$4.29
CFLT
+0.18%
$29.95
GRYP
-10.38%
$1.38
POM
-88.29%
$0.63
HPE
+1.05%
$25.03
MODV
-25.22%
$0.43
BMNR
0.00%
$39.21
CHR
-2.67%
$0.04
AMZN
+1.08%
$230.40
ADVB
-5.59%
$0.34
GPK
-8.66%
$14.23
BBD
+0.30%
$3.33
QBTS
-2.48%
$27.62
EXK
+4.48%
$8.86
SIDU
+29.28%
$1.02
F
+0.22%
$13.11
DVLT
-6.36%
$1.47
TWOH
+16.66%
$0.00
GOOGL
-0.30%
$316.12
JBLU
+0.20%
$4.96
AAL
-1.36%
$14.82
BLNK
-7.43%
$0.93
CHWY
-1.23%
$34.41
IQ
-1.93%
$2.03
CRWV
-4.34%
$86.72
MSFT
-2.92%
$477.63
BBGI
+186.66%
$11.61
IREN
-4.80%
$44.58
BMNU
+0.79%
$10.79
GRAB
-0.87%
$5.10
CIFR
-3.60%
$18.85
HBAN
+1.20%
$17.19
SHOT
-74.37%
$0.39
BAC
+0.61%
$53.87
BTBT
-2.10%
$2.32
PFE
+0.50%
$25.45
KVUE
+1.26%
$17.23
ZAPP
-46.30%
$0.15
ACHR
-1.21%
$8.52
MARA
-2.89%
$11.89
PLTD
-2.98%
$6.33
IXHL
-5.53%
$0.39
MIGI
+56.24%
$7.18
PFSA
-6.95%
$0.18
SOLT
+9.15%
$8.35
HLN
-0.95%
$9.31
CVS
+2.23%
$78.24
SMR
-4.54%
$20.35
YGMZ
-17.83%
$0.05
COMP
+4.03%
$10.84
RDW
+6.89%
$7.29
BTE
-0.64%
$3.07
T
-0.22%
$24.45
QUBT
-4.80%
$12.57
WULF
-0.96%
$15.43
PLAB
+40.13%
$36.00
TNFA
-4.92%
$6.56
VZ
-0.57%
$39.90
IVP
-19.74%
$0.06
SPR
+0.22%
$39.50
NIO
+0.10%
$5.03
AMD
-1.07%
$219.23

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.